MiR-34a biomarker may rule-out NAFLD among healthy patients

For healthy patients, miR-34a may be a reliable biomarker to effectively rule-out nonalcoholic fatty liver disease, according to research presented at The Digital International Liver Congress.“MiR-34a concentrations increase with the presence of NAFLD and [nonalcoholic steatohepatitis],” Rémy Hanf, PhD, said during his presentation. “It distinguishes healthy [patients] for these populations. It has improved diagnostic components relative to other components and other NASH biomarkers. Among patients with suspicion of NAFLD, it could contribute to the identification ofRead More

Share on facebook
Share on twitter
Share on linkedin